Virtual Medicinal Product (VMP)
-
Atovaquone 750mg/5ml oral suspension sugar free
Name Details
|
Current Name
Atovaquone 750mg/5ml oral suspension sugar free
|
Start Date
28-05-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Free From
-
Sugar-free
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
P01AX06
| BNF |
|
Current BNF
05040800
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
05040800
|
Start Date
24-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 35904211000001105 |
18-10-2018 |
|
| 325007009 |
28-05-2003 |
17-10-2018 |
VMP Ingredients
VMP ingredients table
| Atovaquone |
Based on Ingredient Substance |
|
150 mg |
1 ml |
Name
Atovaquone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Atovaquone
-
VMP
(Current) Atovaquone 750mg/5ml oral suspension...
Virtual Medicinal Product Pack (VMPP) Information